Professional Documents
Culture Documents
RIBOZYME - Deepti
RIBOZYME - Deepti
Deepti
M.Sc MBT
2nd Semester
INTRODUCTION
All known enzymes were proteins.
It was discovered that some RNA molecules also have
enzymatic property i.e., catalysing covalent changes in the
structure of substrates.
These ribonucleic acids with enzyme like activity were
named RIBOZYME.
The first ribozyme were discovered in the 1980s by
Thomas R. Cech and Sidney Altman.
These ribozymes were found in the intron of an RNA
transcript, which removed itself from the transcript.
In 1989, Thomas R. Cech and Sidney
Altman won the nobel prize in chemistry for
their “discovery of catalytic properties of
RNA.”
The term “ribozyme” was first introduced
by Kelly Kruger et al. in 1982 in a paper
published in cell.
The few known naturally occurring
ribozymes are :
RNase P
Group I and group II introns
Leadzyme
Hairpin ribozyme
Hammerhead ribozyme
HDV (hepatitis Delta Virus) ribozyme
Classes of Ribozymes
RNAs are broadly grouped into two classes based on their
size and reaction mechanisms:
Large ribozymes (hundreds of nucleotides) and
small ribozymes (less than one hundred nucleotides).
Group I Introns
Group I introns are the only class of introns whose
splicing acquires a free guanine nucleoside.
Group I introns are found in plant and fungal
mitochondria, bacteriophage, eubacteria and
chloroplast tRNA.
Group I introns have phylogenetically conserved
secondary structures.
Group I introns generally consist of hundreds of
nucleotides.
The enzymatic activity of group I introns involve a
two step transesterification with a requirement for a
divalent cation, such as magnesium and a guanosine
co-factor.
Group II Introns
Group II introns are commonly found in
mitochondrials genes in plants,fungi,yeast and other
lower eukaryotes.
In vitro cleavage requirs high Mg2+ concentration and
monovalent cation such as K+ and under physiological
salt conditions a hydrolytic mechanism, in which a
water molecule is positioned for attack tends to
dominate in vitro analyses.
It has been demonstrated that group II introns can be
redirected to insert themselves into therapeutically
relevant DNA target sites into human cells.
RNase P
RNase P is a ubiquitous enzyme that acts as an
endonuclease to generate the mature 5’-end of the tRNA
precursors.
In bacteria, RNase P exists as a ribonucleoprotein
complex, consisting of a long RNA, typically 300-400
nucleotides in length and a small protein of
approximately 14kDa.
RNase P can be considered to be the only known true,
naturally occurring trans- cleaving RNA enzyme.
Further RNase P is one of two known multiple turnover
ribozymes in nature, the discovery of which earned
Professor Sidney Altman the Nobel Prize in chemistry in
1989.
It has been shown that human nuclear RNase P is
required for the normal and efficient transcription of
various small non-coding RNA genes, such as
tRNA,which are transcribed by RNA polymerase III.
RNase P is unique in that it consists of both RNA and
protein subunits,but all of the catalytic activity resides
in the RNA subunit.
The protein subunit is necessary for in vivo activity,
but under high Mg2+ and monovalent salt
concentrations the RNA portion itself is sufficient for
catalysis.
Artificial ribozymes
Artificially produced self-cleaving RNAs that have
good enzymatic activity have been produced.
Zang and Breaker isolated self-cleaving RNAs by
in-vitro selection of RNAs originating from
random-sequence RNAs.
The technique used to discover artificial ribozymes
involve Darwinian evolution. This approach takes
advantage of RNAs dual nature as a catalyst and as
an informational polymer.
Leadzyme
Leadzyme is a small ribozyme that was artificially
made using in vitro selection techniques.
Leadzyme is able to cleave RNA in the presence of
lead.
The structure of leadzyme has been determined by
X-ray crystallography.
Ligase ribozymes
RNA ligase ribozyme were the first of several
types of synthetic ribozymes produced by in vitro
evolution and selection techniques.
They are an important class of ribozyme because
they catalyse the assmebly of RNA fragments into
RNA polymers by forming phosphodiester bond.
Applications
Ribozymes as therapeutic agents
They have been proposed for treatment of a variety
of diseases including infectious diseases and cancer.
The first step to use ribozyme as therapeutic agent
is designing the ribozyme in which critical
properties such as specificity and turnover should
be considered.
After designing the second step is delivery of
catalytic oligonucleotides itno the desired
subcellular compartment of the targeted cell
population within an population.
Advantages of ribozyme in clinical
application
Ribozymes including hammerhead ribozymes, can be
used in the study of gene function and gene therapy for
diseases.
The property of ribozyme makes them suitable in the
research of genetics and developmental biology.
The other important application of ribozyme is to
develop new drugs and protocols for gene therapy.
By protecting cells against viral expression cytopatheic
effects, ribozymes may promote survival of
populations of functional transduced cells in
vivo,leading to increased therapeutic effects over time.
By producing only therapeutic RNAs, ribozymes are
likely to avoid entirely or at least largely the
problems of immune eradication of transduced cells
or production of autoimmune antibodies.